Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guayusa is a **caffeinated herbal tea** derived from the leaves of the Ilex guayusa tree, native to the Ecuadorian Amazon and cultivated for thousands of years, especially among the Kichwa people[1][2][3]. Traditionally consumed as a morning beverage, it is used for its stimulating effects, believed to improve energy, alertness, mood, digestion, and immune function[1][2][3][4][5]. Guayusa contains several bioactive compounds, most notably **caffeine, theobromine, L-theanine, polyphenols (especially catechins), chlorogenic acid, ursolic acid, amyrins, and guanidine derivatives**[1][5]. Its main pharmacological activities are: - **Stimulant (caffeine, theobromine, L-theanine):** boosting mental and physical energy, concentration, and mood[1][2][5][7]. - **Antioxidant:** polyphenols and catechins combat oxidative stress and may help with chronic disease prevention[1][5]. - **Metabolic modulator:** caffeine and related compounds promote fat oxidation and weight loss; ursolic acid activates TGR5, which regulates lipid and glucose metabolism; guanidine derivatives act as hypoglycemic agents[1][5]. - **Anti-inflammatory and analgesic:** amyrins and caffeoylquinic acids suppress nitric oxide production and may reduce pain and inflammation[1]. - **Antimicrobial:** reported activity against some bacterial and protozoal agents[1]. Traditional and contemporary uses further include **appetite suppression, treating colic, menstrual discomfort, malaria, respiratory and digestive complaints, fertility issues**[1][2][3][4][5]. Guayusa is commercially available as dried whole leaves, tea bags, and as an ingredient in energy drinks and supplements[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guayusa.